<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02599597</url>
  </required_header>
  <id_info>
    <org_study_id>rel-prev</org_study_id>
    <nct_id>NCT02599597</nct_id>
  </id_info>
  <brief_title>Prevention of Depressive Relapse by Means of Physical Exercise and Lifestyle</brief_title>
  <official_title>Prevention of Depressive Relapse by Means of Physical Exercise and Lifestyle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lund University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Depression treatments including physical activity and sleep management has been shown to
      relieve depressive symptoms among participants suffering depressive episodes. This study
      evaluates the potential of these methods as prevention of depressive relapse or recurrence
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depressive relapse (change in diagnostic status, SCID-I)</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>Monthly screening via Montgomery-Asberg Depression Rating Scale - Self rated &amp; Structured Clinical Interview for DSM IV</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in depressive symptoms (MADRS-S)</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in depressive symptoms (MADRS-S)</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in depressive symptoms (MADRS-S)</measure>
    <time_frame>Monthly, 0-12 months</time_frame>
    <description>Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in health related quality of life (EQ-5D)</measure>
    <time_frame>Baseline - 3 months</time_frame>
    <description>Health related quality of life will be measured by an internet based version of the EQ-5D.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in health related quality of life (EQ-5D)</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Health related quality of life will be measured by an internet based version of the EQ-5D.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in health related quality of life (EQ-5D)</measure>
    <time_frame>Baseline - 9 months</time_frame>
    <description>Health related quality of life will be measured by an internet based version of the EQ-5D.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in health related quality of life (EQ-5D)</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>Health related quality of life will be measured by an internet based version of the EQ-5D.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Outcomes Questionnaire 45 (OQ-45)</measure>
    <time_frame>Baseline - 3 months</time_frame>
    <description>The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Outcomes Questionnaire 45 (OQ-45)</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Outcomes Questionnaire 45 (OQ-45)</measure>
    <time_frame>Baseline - 9 months</time_frame>
    <description>The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Outcomes Questionnaire 45 (OQ-45)</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>Baseline - 3 months</time_frame>
    <description>The International Physical Activity Questionnaire is a measure of physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>The International Physical Activity Questionnaire is a measure of physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>Baseline - 9 months</time_frame>
    <description>The International Physical Activity Questionnaire is a measure of physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>The International Physical Activity Questionnaire is a measure of physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morisky Medication Adherence Scale (MMAS-8)</measure>
    <time_frame>Baseline - 3 months</time_frame>
    <description>Self-reported measure of medication adherence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morisky Medication Adherence Scale (MMAS-8)</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Self-reported measure of medication adherence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morisky Medication Adherence Scale (MMAS-8)</measure>
    <time_frame>Baseline - 9 months</time_frame>
    <description>Self-reported measure of medication adherence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morisky Medication Adherence Scale (MMAS-8)</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>Self-reported measure of medication adherence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia Severity Index (ISI)</measure>
    <time_frame>Baseline - 3 months</time_frame>
    <description>Insomnia issues</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia Severity Index (ISI)</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Insomnia issues</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia Severity Index (ISI)</measure>
    <time_frame>Baseline - 9 months</time_frame>
    <description>Insomnia issues</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia Severity Index (ISI)</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>Insomnia issues</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol Use Disorder Identification Test (AUDIT)</measure>
    <time_frame>Baseline - 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol Use Disorder Identification Test (AUDIT)</measure>
    <time_frame>Baseline - 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol Use Disorder Identification Test (AUDIT)</measure>
    <time_frame>Baseline - 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol Use Disorder Identification Test (AUDIT)</measure>
    <time_frame>Baseline - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to depressive relapse</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>Time to depressive relapse is recorded as secondary outcome variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self reported treatment seeking</measure>
    <time_frame>Baseline - 12 months</time_frame>
    <description>Treatment seeking among participants is recorded as secondary outcome variable</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Therapist-assisted iCBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet-delivered cognitive behavioral therapy (iCBT), containing physical activity and sleep management for preventing depressive relapse. Monthly depression screening with therapist feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monthly screening with feedback</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Monthly depression screening with therapist feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention, follow-up along with all participants at 6 and 12-months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Therapist-assisted iCBT</intervention_name>
    <description>13 week long individualized prevention program containing, physical activation, sleep management, tailored cognitive behavioral therapy for individual problems.</description>
    <arm_group_label>Therapist-assisted iCBT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Monthly screening with feedback</intervention_name>
    <description>Participants are screened with a depression inventory each month and receives feedback from a therapist on the results</description>
    <arm_group_label>Therapist-assisted iCBT</arm_group_label>
    <arm_group_label>Monthly screening with feedback</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A history of at least one episode of Major Depression.

          -  If medicating - Taking a stable (since one month) and therapeutic dosage of
             antidepressant medication

          -  Being able to read and write Swedish

          -  Having access to the internet

        Exclusion Criteria:

          -  Fulfilling the criteria for Major depression

          -  Bipolar disorder

          -  Psychosis

          -  Substance abuse

          -  Suicidality

          -  Currently in psychotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars-Gunnar Lundh, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University, Departement of psychology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olof Johansson, MD</last_name>
    <phone>+46708196177</phone>
    <email>olof.johansson@psy.lu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vuxenpsykiatrimottagning allmänpsykiatri Fosievägen Malmö</name>
      <address>
        <city>Malmö</city>
        <state>Skåne</state>
        <zip>21431</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olof Johansson, M.Sc</last_name>
      <phone>+46708196177</phone>
      <email>olof.johansson@psy.lu.se</email>
    </contact>
    <contact_backup>
      <last_name>Anna Andersen-Blad</last_name>
      <phone>+4640333587</phone>
      <email>Anna.Andersen-Blad@skane.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2015</study_first_submitted>
  <study_first_submitted_qc>November 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2015</study_first_posted>
  <last_update_submitted>June 29, 2017</last_update_submitted>
  <last_update_submitted_qc>June 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lund University</investigator_affiliation>
    <investigator_full_name>Olof Johansson</investigator_full_name>
    <investigator_title>PhD student</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

